Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
The Chemours Company
CC
NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $3.0B
$18.88
▼ -6.26%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$10.44 - $28.67
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 58.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Established brand portfolio with Ti-Pure and BaiMax commanding market recognition
- Vertically integrated production capabilities and global distribution network
- Specialized expertise in high-performance materials for regulated industries
- Strong customer relationships across diverse end-markets reducing concentration risk
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Rising demand for sustainable coatings and eco-friendly refrigerants
Value
Attractively priced below Specialty Chemicals peer average
Momentum
Weak
-6.5% over 3m
Quality
Thin
Solid business
Dividend
Modest
1.74% yield
Smart-money signal
Who's buying CC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 4, 2026
MAY 5, 2026
Reported EPS of $0.05 vs -$0.05 consensus (+200.0% surprise). Revenue of $1.4B vs $1.4B expected (-1.3%).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+200.0%
Next: May 4, 2026
Revenue trend · last 8Q
—
—
-1%
+0%
+4%
-0%
-5%
+1%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$1.6B
$1.5B
$1.4B
$1.4B
$1.6B
$1.5B
$1.3B
$1.4B
Margins · last 8Q
Gross
—
Operating
—
Profit
-2.1%
Wall Street consensus
8 analysts · 63% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
63%
Hold
38%
Sell
0%
Median Price Target
$29.00
▲ +53.6% vs $18.88
Latest: JP Morgan · May 21, 2026
6 analysts covering